{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:30:04Z","timestamp":1773948604214,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK National Screening Committee"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Mitochondrial trifunctional protein (MTP) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiencies are rare fatty acid \u03b2-oxidation disorders. Without dietary management the conditions are life-threatening. We conducted a systematic review to investigate whether pre-symptomatic dietary management following newborn screening provides better outcomes than treatment following symptomatic detection.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We searched Web of Science, Medline, Pre-Medline, Embase and the Cochrane Library up to 23rd April 2018. Two reviewers independently screened titles, abstracts and full texts for eligibility and quality appraised the studies. Data extraction was performed by one reviewer and checked by another.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We included 13 articles out of 7483 unique records. The 13 articles reported on 11 patient groups, including 174 people with LCHAD deficiency, 18 people with MTP deficiency and 12 people with undifferentiated LCHAD\/MTP deficiency. Study quality was moderate to weak in all studies. Included studies suggested fewer heart and liver problems in screen-detected patients, but inconsistent results for mortality. Follow up analyses compared long-term outcomes of (1) pre-symptomatically versus symptomatically treated patients, (2) screened versus unscreened patients, and (3) asymptomatic screen-detected, symptomatic screen-detected, and clinically diagnosed patients in each study. For follow up analyses 1 and 2, we found few statistically significant differences in the long-term outcomes. For follow up analysis 3 we found a significant difference for only one comparison, in the incidence of cardiomyopathy between the three groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>There is some evidence that dietary management following screen-detection might be associated with a lower incidence of some LCHAD and MTP deficiency-related complications. However, the evidence base is limited by small study sizes, quality issues and risk of confounding. An internationally collaborative research effort is needed to fully examine the risks and the benefits to pre-emptive dietary management with particular attention paid to disease severity and treatment group.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-019-1226-y","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T15:03:20Z","timestamp":1573830200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-9684","authenticated-orcid":false,"given":"Hannah","family":"Fraser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Geppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Connock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Taylor-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Stinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10545-014-9729-0","volume":"37","author":"S Moorthie","year":"2014","unstructured":"Moorthie S, et al. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis. 2014;37:889\u201398.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1226_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF01799383","volume":"13","author":"RJA Wanders","year":"1990","unstructured":"Wanders RJA, et al. Long-chain 3-HYDROXYACYL-COA dehydrogenase-deficiency - identification of a new inborn error of mitochondrial fatty-acid BETA-oxidation. J Inherit Metab Dis. 1990;13(3):311\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1226_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF01799383","volume":"13","author":"R Wanders","year":"1990","unstructured":"Wanders R, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid\u03b2-oxidation. J Inherit Metab Dis. 1990;13(3):311\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1226_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mob.2002.125893","volume":"187","author":"Z Yang","year":"2002","unstructured":"Yang Z, et al. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol. 2002;187(3):715\u201320.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1226_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10545-010-9188-1","volume":"33","author":"U Spiekerkoetter","year":"2010","unstructured":"Spiekerkoetter U, et al. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis. 2010;33(5):555\u201361.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1226_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10545-009-1125-9","volume":"32","author":"U Spiekerkoetter","year":"2009","unstructured":"Spiekerkoetter U, et al. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis. 2009;32(4):488\u201397.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"1226_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/jhg.2017.52","volume":"62","author":"R Bo","year":"2017","unstructured":"Bo R, et al. Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases. J Hum Genet. 2017;62(9):809\u201314.","journal-title":"J Hum Genet"},{"issue":"2","key":"1226_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ymgme.2005.02.002","volume":"85","author":"J Sander","year":"2005","unstructured":"Sander J, et al. Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab. 2005;85(2):108\u201314.","journal-title":"Mol Genet Metab"},{"issue":"2\u20133","key":"1226_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ymgme.2010.07.003","volume":"101","author":"A Sperk","year":"2010","unstructured":"Sperk A, Mueller M, Spiekerkoetter U. Outcome in six patients with mitochondrial trifunctional protein disorders identified by newborn screening. Mol Genet Metab. 2010;101(2\u20133):205\u20137.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1226_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ymgme.2011.04.006","volume":"103","author":"A. Boutron","year":"2011","unstructured":"Boutron, A., et al., Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. Molecular Genetics and Metabolism. 2011;103(4):341\u2013348.","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"1226_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1067\/mpd.2003.231","volume":"142","author":"ME den Boer","year":"2003","unstructured":"den Boer ME, et al. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003;142(6):684\u20139.","journal-title":"J Pediatr"},{"issue":"1","key":"1226_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1542\/peds.109.1.99","volume":"109","author":"ME den Boer","year":"2002","unstructured":"den Boer ME, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109(1):99\u2013104.","journal-title":"Pediatrics"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13023-015-0236-7","volume":"10","author":"D Karall","year":"2015","unstructured":"Karall D, et al. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with long-chain 3-Hydroxy acyl CoA dehydrogenase deficiency (LCHADD). Orphanet J Rare Dis. 2015;10:21.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1226_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1172-6-44","volume":"6","author":"M Lindner","year":"2011","unstructured":"Lindner M, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from south-West Germany. Orphanet J Rare Dis. 2011;6(1):44.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1226_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ymgme.2012.06.006","volume":"107","author":"AM Lund","year":"2012","unstructured":"Lund AM, et al. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening. Mol Genetics Metab. 2012;107(3):281\u201393.","journal-title":"Mol Genetics Metab"},{"issue":"1","key":"1226_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10545-006-0228-9","volume":"29","author":"DM Frazier","year":"2006","unstructured":"Frazier DM, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis. 2006;29(1):76\u201385.","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"1226_CR17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/clinchem\/47.11.1945","volume":"47","author":"TH Zytkovicz","year":"2001","unstructured":"Zytkovicz TH, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England newborn screening program. Clin Chem. 2001;47(11):1945\u201355.","journal-title":"Clin Chem"},{"issue":"3","key":"1226_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1524-475X.2004.04006.x","volume":"1","author":"B Thomas","year":"2004","unstructured":"Thomas B, et al. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid-Based Nurs. 2004;1(3):176\u201384.","journal-title":"Worldviews Evid-Based Nurs"},{"key":"1226_CR19","unstructured":"Effective Public Health Practice Project. Quality Assessment Tool For Quantitative Studies. Hamilton, ON: Effective Public Health Practice Project. 1998 20\/06\/2019]; Available from: https:\/\/merst.ca\/wp-content\/uploads\/2018\/02\/quality-assessment-tool_2010.pdf"},{"key":"1226_CR20","unstructured":"Nyaga V.N., M. Arbyn, and M.J.A.o.P.H. Aerts, Metaprop: a Stata command to perform meta-analysis of binomial data.\u00a0Archives of Public Health. 2014;72(1):39."},{"issue":"3","key":"1226_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-0420.2007.01121.x","volume":"86","author":"KT Fahnehjelm","year":"2008","unstructured":"Fahnehjelm KT, et al. Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up. Acta Ophthalmol. 2008;86(3):329\u201337.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"1226_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/apa.13536","volume":"105","author":"KT Fahnehjelm","year":"2016","unstructured":"Fahnehjelm KT, et al. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function. Acta Paediatr. 2016;105(12):1451\u201360.","journal-title":"Acta Paediatr"},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/8904_2012_164","volume":"8","author":"CB Haglind","year":"2013","unstructured":"Haglind CB, et al. Growth in long-chain 3-Hydroxyacyl-CoA dehydrogenase deficiency. Jimd Reports. 2013;8:81\u201390.","journal-title":"Jimd Reports"},{"issue":"5","key":"1226_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/apa.13313","volume":"105","author":"T Immonen","year":"2016","unstructured":"Immonen T, et al. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr. 2016;105(5):549\u201354.","journal-title":"Acta Paediatr"},{"issue":"10","key":"1226_CR25","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.ophtha.2016.06.048","volume":"123","author":"EA Boese","year":"2016","unstructured":"Boese EA, et al. Characterization of Chorioretinopathy associated with mitochondrial Trifunctional protein disorders: long-term follow-up of 21 cases. Ophthalmology. 2016;123(10):2183\u201395.","journal-title":"Ophthalmology"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/8904_2016_558","volume":"31","author":"I De Biase","year":"2017","unstructured":"De Biase I, et al. Diagnosis, treatment, and clinical outcome of patients with mitochondrial Trifunctional protein\/long-chain 3-Hydroxy acyl-CoA dehydrogenase deficiency. Jimd Reports. 2017;31:63\u201371.","journal-title":"Jimd Reports"},{"issue":"6","key":"1226_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","volume":"40","author":"MB Gillingham","year":"2017","unstructured":"Gillingham MB, et al. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial. J Inherit Metab Dis. 2017;40(6):831\u201343.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1226_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12887-018-1069-z","volume":"18","author":"E Kang","year":"2018","unstructured":"Kang E, et al. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening. BMC Pediatr. 2018;18(1):103.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1226_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10545-010-9244-x","volume":"34","author":"J Sykut-Cegielska","year":"2011","unstructured":"Sykut-Cegielska J, et al. Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening. J Inherit Metab Dis. 2011;34(1):185\u201395.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1226-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1226-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1226-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:13:39Z","timestamp":1605312819000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1226-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1226-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}